Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59dff55f3584472dbf7f7d81998de6b7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C48-297 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C2793-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C2793-0009 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C48-0022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C47-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 |
filingDate |
2014-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1714b42437dc5893d2e146411cbae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c012984d0d7abf5e9094dc4ca05a271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97681dd42e77c232b327d2879e365580 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a03bb6441c0c3eb126e04bdbbcf582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7cc8bb20da0749a68e34c3b3f1cb3f |
publicationDate |
2015-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015098996-A1 |
titleOfInvention |
Nicotine lozenge |
abstract |
A nicotine lozenge provided herein includes a body that is partially or wholly receivable in an oral cavity. The body includes a soluble-fiber matrix and nicotine or a derivative thereof dispersed in the soluble-fiber matrix. In some cases, a nicotine lozenge provided herein includes at least 40 weight percent of soluble fiber. In some cases, soluble fiber in a nicotine lozenge provided herein can include maltodextrin. The nicotine lozenge is adapted to release the nicotine or a derivative thereof from the body when the body is received within the oral cavity of an adult consumer and exposed to saliva. A method of making nicotine lozenges provided herein includes forming a molten mixture of at least 40 weight percent soluble fiber, nicotine, and less than 15 weight percent water while maintaining a mixture temperature of less than 150° C. and portioning the molten mixture into a plurality of nicotine lozenges. In some cases, the ingredients can be mixed to form the molten mixture in an extruder. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-2050380-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3397081-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017079832-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610526-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216324-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617744-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016381372-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019502756-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021201765-A1 |
priorityDate |
2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |